SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------------
FORM 8-K
----------------------------
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 14, 1998
----------------
INNOVIR LABORATORIES, INC.
------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-21972 13-3536290
- ------------------------------ ----------- ------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
510 East 73rd Street, New York, NY 10021
- ---------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (212) 249-4703
--------------------
Not Applicable
--------------------------------------------------------------
(Former name or former address, if changed since last report)
1
ITEM 5. OTHER EVENTS.
On October 14, 1998, Innovir Laboratories, Inc. issued the press release
filed herewith as Exhibit 99.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) FINANCIAL STATEMENTS
No financial statements are required to be filed as a part of this
report.
(b) PRO FORMA FINANCIAL INFORMATION
No pro forma financial information is required to be filed as a part
of this report.
(c) EXHIBITS
99 Press release, dated October 14, 1998.
All other Items of this report are inapplicable.
2
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Innovir Laboratories, Inc.
Date: October 20, 1998 By:/s/ Francis M. O'Connell
------------------------
Name: Francis M. O'Connell
Title: Chief Financial Officer
3
EXHIBIT INDEX
-------------
99 Press release, dated October 14, 1998.
4